• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Resmed Inc (NY: RMD )

    245.63 -0.11 (-0.04%)
    Official Closing Price Updated: 7:00 PM EST, Nov 6, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 802,462
    Open 248.74
    Bid (Size) 223.04 (1)
    Ask (Size) 250.00 (1)
    Prev. Close 245.74
    Today's Range 241.97 - 250.00
    52wk Range 140.81 - 260.49
    Shares Outstanding 146,234,244
    Dividend Yield 0.78%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    ResMed Announces Participation in the UBS Global Healthcare Conference
    From ResMed Inc.
    Via GlobeNewswire
    P/E Ratio Insights for ResMed
    Via Benzinga

    Performance

    YTD
    +42.99%
    +42.99%
    1 Month
    +5.74%
    +5.74%
    3 Month
    +16.45%
    +16.45%
    6 Month
    +15.38%
    +15.38%
    1 Year
    +63.47%
    +63.47%

    More News

    Read More
    Tech Stocks Rally As Investors Await Magnificent 7 Earnings; Dollar Eyes Fourth Straight Positive Week: What's Driving Markets Friday?
    Via Benzinga
    Cracking The Code: Understanding Analyst Reviews For ResMed
    Via Benzinga
    A Peek at ResMed's Future Earnings
    Via Benzinga
    Stock Market Mixed But Nasdaq Hits Record High As Tesla Leads Earnings Winners: Weekly Review
    Via Investor's Business Daily
    Sleep Apnea Device Maker ResMed Is A Durable MedTech, With Positive Fundamentals, Says Analyst
    Via Benzinga
    My 3 Favorite Stocks to Buy Right Now
    Via The Motley Fool
    Obesity Drugs-Tied ResMed Edges Higher On Quarterly Beat
    Via Investor's Business Daily
    Is RESMED INC (NYSE:RMD) suited for quality investing?
    Via Chartmill
    Expert Outlook: ResMed Through The Eyes Of 7 Analysts
    Via Benzinga
    Reasonable growth and debt and a high ROIC for RESMED INC (NYSE:RMD).
    Via Chartmill
    ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2025
    From ResMed Inc.
    Via GlobeNewswire
    ResMed to Report First Quarter Fiscal 2025 Earnings on October 24, 2024
    From ResMed Inc.
    Via GlobeNewswire
    ResMed Unveils 2030 Strategy to Drive Growth, Profitability, and Shareholder Returns
    From ResMed Inc.
    Via GlobeNewswire
    UPDATE -- ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health
    From ResMed Inc.
    Via GlobeNewswire
    UPDATE -- ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health
    From ResMed Inc.
    Via GlobeNewswire
    ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health
    From ResMed Inc.
    Via GlobeNewswire
    ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health
    From ResMed Inc.
    Via GlobeNewswire
    Wall Street's Top 10 Stock Calls This Week - Saturday, Sept. 21
    Via Talk Markets
    Why ResMed Stock Tumbled by 5% Today
    Via The Motley Fool
    Stocks Edge Lower As Fed Rate Decision Looms, Treasury Yields Rise As Odds Improve For Smaller Cut: What's Driving Markets Wednesday?
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    ResMed to Host Its 2024 Investor Day on September 30, 2024, at the New York Stock Exchange
    From ResMed Inc.
    Via GlobeNewswire
    Vaping Expected to Increase COPD Health and Economic Burden by 2050
    From ResMed Inc.
    Via GlobeNewswire
    Here's How Much You Would Have Made Owning ResMed Stock In The Last 15 Years
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.